Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Net Income (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Net Income for 16 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income rose 126.04% to $1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 110.08% increase, with the full-year FY2024 number at -$16.4 million, down 2589.09% from a year prior.
  • Net Income was $1.3 million for Q3 2025 at Xtant Medical Holdings, down from $3.6 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $9.2 million in Q3 2023 to a low of -$5.0 million in Q3 2024.
  • A 5-year average of -$1.3 million and a median of -$2.2 million in 2023 define the central range for Net Income.
  • Peak YoY movement for Net Income: crashed 7531.03% in 2022, then soared 492.31% in 2023.
  • Xtant Medical Holdings' Net Income stood at -$2.4 million in 2021, then increased by 7.03% to -$2.2 million in 2022, then tumbled by 94.71% to -$4.3 million in 2023, then grew by 26.93% to -$3.1 million in 2024, then skyrocketed by 141.6% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Net Income are $1.3 million (Q3 2025), $3.6 million (Q2 2025), and $58000.0 (Q1 2025).